AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2012
Jun 12, 2012
30786_dirs_2012-06-12_743ab1fa-7a2e-4583-a188-72915fb24770.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2012-06-10
Reporting Person: GOETZ JOHN (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-10 | Bio-Rad A Common Stock | M | 240 | — | Acquired | 32532.6807 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-10 | Restricted Stock Units | $0 | M | 240 | Disposed | Bio-Rad A Common Stock (240) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 59.4580 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on 3/31/2012.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest in five equal annual installments beginning June 10, 2010.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13